Abstract
Currently, the development of resistance of Enterobacteriaceae bacteria is one of the most important health problems worldwide. Consequently, there is a growing urge for finding new compounds with antibacterial activity. Furthermore, it is very important to find antibacterial compounds with a good pharmacokinetic profile too, which will lead to more efficient and safer drugs. In this work, we have mathematically described a series of antibacterial quinolones by means of molecular topology. We have used molecular descriptors and related them to various pharmacological properties by using multilinear regression (MLR) analysis. The regression functions selected by presenting the best combination of a number of quality and validation metrics allowed for the reliable prediction of clearance (CL), and minimum inhibitory concentration 50 against Enterobacter aerogenes (MIC50Ea) and Proteus mirabilis (MIC50Pm). The obtained results clearly reveal that the combination of molecular topology methods and MLR provides an excellent tool for the prediction of pharmacokinetic properties and microbiological activities in both new and existing compounds with different pharmacological activities.
Funder
ESI InternationalChair@CEU-UCH
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference55 articles.
1. Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics;Tacconelli,2017
2. Health Care-Associated Infection Outbreak Investigations by the Centers for Disease Control and Prevention, 1946-2005
3. WHO Priority Pathogens List for R&D of New Antibiotics
http://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf?ua=1
4. Discovering novel chemotherapeutic drugs for the third millennium
5. Molecular Docking;Morris;Methods Mol. Biol.,2008